• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 40 páginas
Examen

NUR-641E Final Exam Prep | All Possible Questions and Answers | 2026/2027 Updates | 100% Correct –GCU.

Document preview thumbnail
Vista previa 4 fuera de 40 páginas

Prepare for the GCU NUR-641E Final Exam with this updated 2026/2027 exam preparation resource. Designed for nursing students, this comprehensive guide provides structured topic reviews, practice questions, detailed rationales, and focused concept summaries to support effective final exam preparation. The resource covers essential NUR-641E nursing concepts, clinical decision-making, patient assessment, evidence-based practice, therapeutic interventions, pharmacologic principles, patient safety, health promotion, professional nursing responsibilities, and application of nursing knowledge to realistic clinical scenarios. Practice questions with detailed rationales help reinforce key concepts, strengthen clinical judgment, and improve critical-thinking skills. Designed for efficient review and knowledge retention, this resource helps GCU students prepare confidently for the NUR-641E final assessment.

Vista previa del contenido

NUR-641E Final Exam Prep | All Possible Questions
and Answers | Updates | 100% Correct –GCU.

Section 1: Pharmacokinetics & Pharmacodynamics


1. Pharmacokinetics involves which four processes?
A) Absorption, digestion, metabolism, excretion
B) Absorption, distribution, metabolism, elimination
C) Administration, distribution, metabolism, elimination
D) Absorption, distribution, metabolism, transport
Answer B: Absorption, distribution, metabolism, elimination
Rationale: Pharmacokinetics describes how the body affects a drug through
absorption, distribution, metabolism, and elimination.




2. Which route of administration has the highest bioavailability?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
Answer C: Intravenous
Rationale: IV administration places the entire dose directly into the bloodstream,
bypassing absorption and first-pass metabolism.

,3. Which route of administration has variable and erratic absorption?
A) Oral
B) Rectal
C) Sublingual
D) Transdermal
Answer B: Rectal
Rationale: Rectal administration has variable absorption due to differences in
blood supply and the presence of feces.




4. Steady state of a drug is usually reached within:
A) 1-2 half-lives
B) 4-5 half-lives
C) 6-8 half-lives
D) 10 half-lives
Answer B: 4-5 half-lives
Rationale: Steady state concentration is typically achieved within 4-5 half-lives of
a drug.




5. The half-life of a drug determines:
A) How quickly it is absorbed
B) How frequently it must be administered and how long toxic effects last
C) How well it binds to receptors
D) Its therapeutic index

,Answer B: How frequently it must be administered and how long toxic effects
last
Rationale: Half-life determines dosing frequency and predicts duration of toxic
effects .




6. Zero-order pharmacokinetics means:
A) Drug metabolism is proportional to concentration
B) Drug is metabolized at a constant rate per unit time
C) Drug absorption is complete
D) Drug distribution is rapid
Answer B: Drug is metabolized at a constant rate per unit time
Rationale: Zero-order kinetics means the drug is metabolized at a constant rate
regardless of concentration .




7. Which of the following is an example of zero-order pharmacokinetics?
A) Warfarin
B) Phenytoin
C) Metformin
D) Lisinopril
Answer B: Phenytoin
Rationale: Phenytoin exhibits zero-order kinetics at therapeutic doses, meaning
small dose increases can cause large increases in blood levels.

, 8. What is the purpose of Phase IV clinical trials?
A) Initial testing in healthy volunteers
B) Comparing drug to placebo
C) Post-marketing surveillance to identify rare adverse effects
D) Laboratory research
Answer C: Post-marketing surveillance to identify rare adverse effects
Rationale: Phase IV studies monitor for adverse effects not identified in earlier
clinical studies . --- ## Section 2: Adverse Drug Reactions & Drug Safety




9. What percentage of adverse drug reactions are pharmacological (type A)?
A) 30-40%
B) 50-60%
C) 85-90%
D) 95-98%
Answer C: 85-90%
Rationale: 85% to 90% of ADRs are pharmacological, meaning they are extensions
of the drug's known effects .




10. Which medication safety organizations are involved in drug safety?
A) ISMP, IOM, Joint Commission, FDA
B) WHO, CDC, NIH
C) AMA, ANA, CDC

Información del documento

Subido en
23 de agosto de 2026
Número de páginas
40
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$19.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
AcademicACHIEVER
3.4
(95)
Vendido
552
Seguidores
24
Artículos
13036
Última venta
9 horas hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes